OTC: ERFSF - Eurofins Scientific SE

Yield per half year: +0.2157%
Sector: Healthcare

Company Analysis Eurofins Scientific SE

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Dividends (2.24%) are higher than the sector average (1.76%).
  • The stock's return over the last year (-23.9%) is higher than the sector average (-28.25%).
  • Current debt level 32.04% is below 100% and has decreased over 5 years from 43.79%.

Disadvantages

  • Price (61.69 $) is higher than fair price (22.23 $)
  • The company's current efficiency (ROE=8.41%) is lower than the sector average (ROE=13.23%)

Similar companies

Eisai Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Sinopharm Group Co., Ltd.

Roche Holding

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Eurofins Scientific SE Healthcare Index
7 days -1.4% -4.2% -0.2%
90 days -10.8% -31.7% 5.5%
1 year -23.9% -28.3% 27.2%

ERFSF vs Sector: Eurofins Scientific SE has outperformed the "Healthcare" sector by 4.36% over the past year.

ERFSF vs Market: Eurofins Scientific SE has significantly underperformed the market by -51.14% over the past year.

Stable price: ERFSF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.

Long period: ERFSF with weekly volatility of -0.4596% over the past year.

3. Summary of the report

3.1. General

P/E: 38.13
P/S: 1.82

3.2. Revenue

EPS 1.75
ROE 8.41%
ROA 3.15%
ROIC 0%
Ebitda margin 18.59%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (61.69 $) is higher than the fair price (22.23 $).

Price is higher than fair: The current price (61.69 $) is 64% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (38.13) is higher than that of the sector as a whole (31.91).

P/E vs Market: The company's P/E (38.13) is lower than that of the market as a whole (46.75).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (3.16) is lower than that of the sector as a whole (3.37).

P/BV vs Market: The company's P/BV (3.16) is higher than that of the market as a whole (-9.03).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (1.82) is lower than that of the sector as a whole (3.27).

P/S vs Market: The company's P/S indicator (1.82) is lower than that of the market as a whole (4.84).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (12.89) is higher than that of the sector as a whole (10.03).

EV/Ebitda vs Market: The company's EV/Ebitda (12.89) is lower than that of the market as a whole (25.06).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 15.99% over the last 5 years.

Earnings Slowdown: The last year's return (6.45%) is below the 5-year average return (15.99%).

Profitability vs Sector: The return for the last year (6.45%) exceeds the return for the sector (-73.63%).

5.4. ROE

ROE vs Sector: The company's ROE (8.41%) is lower than that of the sector as a whole (13.23%).

ROE vs Market: The company's ROE (8.41%) is higher than that of the market as a whole (-8.22%).

5.5. ROA

ROA vs Sector: The company's ROA (3.15%) is lower than that of the sector as a whole (6.16%).

ROA vs Market: The company's ROA (3.15%) is lower than that of the market as a whole (4.87%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).

6. Finance

6.1. Assets and debt

Debt level: (32.04%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 43.79% to 32.04%.

Excess of debt: The debt is not covered by net income, percentage 1017.77%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 2.24% is higher than the average for the sector '1.76%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 2.24% has been steadily paid over the past 7 years, DSI=0.86.

Weak dividend growth: The company's dividend yield 2.24% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (61.86%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Eurofins Scientific SE

9.3. Comments